Displaying drugs 13301 - 13325 of 14030 in total
Disaccharide tripeptide glycerol dipalmitoyl
Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma).
Investigational
Matched Description: … Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma). ... Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination …
BI 2536
BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer).
Investigational
Matched Description: … BI 2536 is under investigation in clinical trial NCT00376623 (Efficacy and Safety of BI 2536 in Advanced …
KAI-1678
KAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia).
Investigational
Matched Description: … to Treat Pain in Subjects With Postherpetic Neuralgia). ... KAI-1678 is under investigation in clinical trial NCT01106716 (Safety and Efficacy Study of KAI-1678 …
Nolasiban
Nolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI).
Investigational
Matched Description: … to Improve Pregnancy Rates in Women Undergoing IVF/ICSI). ... Nolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban …
Mescaline
Mescaline is under investigation in clinical trial NCT05933213 (Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis).
Investigational
Matched Description: … Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis). ... Mescaline is under investigation in clinical trial NCT05933213 (Comparing Mescaline Sodium Enteric-coated …
Isopentane
Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization/fluoride Uptake in an in Situ Model).
Investigational
Matched Description: … /fluoride Uptake in an in Situ Model). ... Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization …
Camrelizumab
Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
Investigational
Matched Description: … Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in …
Cabiralizumab
Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).
Investigational
Matched Description: … in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma). ... Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab …
LY-2624803
LY-2624803 is under investigation in clinical trial NCT01236105 (Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject).
Investigational
Matched Description: … of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject). ... LY-2624803 is under investigation in clinical trial NCT01236105 (Effect of Activated Charcoal and Time …
RSV-604
RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).
Investigational
Matched Description: … Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.). ... RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic …
Technetium Tc-99m epratuzumab
Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).
Investigational
Matched Description: … Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma). ... Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal …
Ningetinib
Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
Investigational
Matched Description: … in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative). ... Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib …
p-Boronophenylalanine
p-Boronophenylalanine is under investigation in clinical trial NCT00039572 (Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain).
Investigational
Matched Description: … in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain). ... p-Boronophenylalanine is under investigation in clinical trial NCT00039572 (Boron Neutron Capture Therapy …
Phosphonothreonine
The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem]
Experimental
Matched Description: … Used as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem] …
PF-04958242
PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.
Investigational
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …
Mannose 6-phosphate
Mannose 6-phosphate has been used in trials studying the treatment of Wound, Cicatrix, Wound-healing, and Re-epithelialisation.
Investigational
Matched Description: … Mannose 6-phosphate has been used in trials studying the treatment of Wound, Cicatrix, Wound-healing, …
Cilengitide
Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.
Investigational
Matched Description: … Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and …
Ibodutant
Ibodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel Syndrome With Diarrhea.
Investigational
Matched Description: … Ibodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel …
Labetuzumab govitecan
Labetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, and Metastatic Colorectal Cancer.
Investigational
Matched Description: … Labetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, …
Icaritin
Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).
Investigational
Matched Description: … Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and …
Perfosfamide
Perfosfamide has been used in trials studying the treatment of Lymphoma, Neuroblastoma, and Multiple Myeloma and Plasma Cell Neoplasm.
Investigational
Matched Description: … Perfosfamide has been used in trials studying the treatment of Lymphoma, Neuroblastoma, and Multiple …
Vantictumab
Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage IV Pancreatic Cancer.
Investigational
Matched Description: … Vantictumab has been used in trials studying the treatment of Solid Tumors, Pancreatic Cancer, and Stage …
Xanomeline
Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium).
Investigational
Matched Description: … Xanomeline is under investigation in clinical trial NCT02831231 (Pilot Study Comparing Effects of Xanomeline …
PX-102
PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).
Investigational
Matched Description: … PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study …
Janagliflozin
Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin).
Investigational
Matched Description: … Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes …
Displaying drugs 13301 - 13325 of 14030 in total